FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988612012> ?p ?o ?g. }

• W1988612012 endingPage "284" @default.
• W1988612012 startingPage "278" @default.
• W1988612012 abstract "A3 adenosine receptor (A3AR) agonists have been reported to modulate cellular proliferation. This work was aimed to investigate the expression and the possible action of A3 receptor in the human thyroid carcinomas. Normal thyroid tissue samples did not express A3 adenosine receptor, while primary thyroid cancer tissues expressed high level of A3AR, as determined by immunohistochemistry analysis. In human papillary thyroid carcinoma cell line, NPA, at concentrations ≥10µM, the A3AR-selective agonist 2-chloro-N6-(3-iodobenzyl)adenosine-5’-N-methylcarboxamide (Cl-IB-MECA) produced inhibition of cell growth, by blocking the G1 cell cycle phase in a concentration- and time-dependent manner. This effect was well correlated with a reduction of protein expression of cyclins D1 and E2 after 24 hours of Cl-IB-MECA treatment. Moreover Cl-IB-MECA induced dephosphorylation of ERK1/2 in a time- and concentration-dependent manner, which in turn inhibits cell proliferation. The effect of Cl-IB-MECA was not prevented by A3AR antagonists, MRS1191 or MRS1523 or FA385. Furthermore, neither nucleoside transporter inhibitors, Dypiridamole and NBTI, nor the A1, A2A and A2B receptors antagonists were able to block the response to Cl-IB-MECA. Although Cl-IB-MECA has been shown to influence cell death and survival in other systems through an A3AR-mediated mechanism, in NPA cells the growth inhibition induced by micromolar concentrations of Cl-IB-MECA appeared not mediated through activation of this receptor and hence that its effects on human papillary carcinoma cell line seem to be independent of the presence of this receptor subtype." @default.
• W1988612012 created "2016-06-24" @default.
• W1988612012 creator A5018449992 @default.
• W1988612012 creator A5041985375 @default.
• W1988612012 creator A5042599468 @default.
• W1988612012 creator A5050600005 @default.
• W1988612012 creator A5051315649 @default.
• W1988612012 creator A5053081412 @default.
• W1988612012 creator A5060976864 @default.
• W1988612012 creator A5064729609 @default.
• W1988612012 creator A5071729844 @default.
• W1988612012 date "2008-02-04" @default.
• W1988612012 modified "2023-09-29" @default.
• W1988612012 title "Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation" @default.
• W1988612012 cites W1522444632 @default.
• W1988612012 cites W1969125109 @default.
• W1988612012 cites W1969866442 @default.
• W1988612012 cites W1971024460 @default.
• W1988612012 cites W1999515465 @default.
• W1988612012 cites W2007934886 @default.
• W1988612012 cites W2021354739 @default.
• W1988612012 cites W2023743215 @default.
• W1988612012 cites W2034658253 @default.
• W1988612012 cites W2034837063 @default.
• W1988612012 cites W2046467234 @default.
• W1988612012 cites W2052081866 @default.
• W1988612012 cites W2057411906 @default.
• W1988612012 cites W2062491181 @default.
• W1988612012 cites W2067901767 @default.
• W1988612012 cites W2077248711 @default.
• W1988612012 cites W2081102609 @default.
• W1988612012 cites W2088746083 @default.
• W1988612012 cites W2090842981 @default.
• W1988612012 cites W2102517422 @default.
• W1988612012 cites W2124351185 @default.
• W1988612012 cites W2133722275 @default.
• W1988612012 cites W2135187058 @default.
• W1988612012 cites W2135205552 @default.
• W1988612012 cites W2146436199 @default.
• W1988612012 cites W2161018896 @default.
• W1988612012 cites W2165260035 @default.
• W1988612012 cites W2169096629 @default.
• W1988612012 cites W2169920833 @default.
• W1988612012 cites W2512906422 @default.
• W1988612012 doi "https://doi.org/10.4161/cbt.7.2.5301" @default.
• W1988612012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18059189" @default.
• W1988612012 hasPublicationYear "2008" @default.
• W1988612012 type Work @default.
• W1988612012 sameAs 1988612012 @default.
• W1988612012 citedByCount "52" @default.
• W1988612012 countsByYear W19886120122012 @default.
• W1988612012 countsByYear W19886120122013 @default.
• W1988612012 countsByYear W19886120122015 @default.
• W1988612012 countsByYear W19886120122016 @default.
• W1988612012 countsByYear W19886120122017 @default.
• W1988612012 countsByYear W19886120122018 @default.
• W1988612012 countsByYear W19886120122019 @default.
• W1988612012 countsByYear W19886120122020 @default.
• W1988612012 countsByYear W19886120122021 @default.
• W1988612012 countsByYear W19886120122022 @default.
• W1988612012 crossrefType "journal-article" @default.
• W1988612012 hasAuthorship W1988612012A5018449992 @default.
• W1988612012 hasAuthorship W1988612012A5041985375 @default.
• W1988612012 hasAuthorship W1988612012A5042599468 @default.
• W1988612012 hasAuthorship W1988612012A5050600005 @default.
• W1988612012 hasAuthorship W1988612012A5051315649 @default.
• W1988612012 hasAuthorship W1988612012A5053081412 @default.
• W1988612012 hasAuthorship W1988612012A5060976864 @default.
• W1988612012 hasAuthorship W1988612012A5064729609 @default.
• W1988612012 hasAuthorship W1988612012A5071729844 @default.
• W1988612012 hasBestOaLocation W19886120121 @default.
• W1988612012 hasConcept C126322002 @default.
• W1988612012 hasConcept C134018914 @default.
• W1988612012 hasConcept C158424129 @default.
• W1988612012 hasConcept C170493617 @default.
• W1988612012 hasConcept C185592680 @default.
• W1988612012 hasConcept C2776991684 @default.
• W1988612012 hasConcept C2778938600 @default.
• W1988612012 hasConcept C2779761222 @default.
• W1988612012 hasConcept C502942594 @default.
• W1988612012 hasConcept C526584372 @default.
• W1988612012 hasConcept C55493867 @default.
• W1988612012 hasConcept C62112901 @default.
• W1988612012 hasConcept C67907053 @default.
• W1988612012 hasConcept C71924100 @default.
• W1988612012 hasConcept C86803240 @default.
• W1988612012 hasConcept C95444343 @default.
• W1988612012 hasConceptScore W1988612012C126322002 @default.
• W1988612012 hasConceptScore W1988612012C134018914 @default.
• W1988612012 hasConceptScore W1988612012C158424129 @default.
• W1988612012 hasConceptScore W1988612012C170493617 @default.
• W1988612012 hasConceptScore W1988612012C185592680 @default.
• W1988612012 hasConceptScore W1988612012C2776991684 @default.
• W1988612012 hasConceptScore W1988612012C2778938600 @default.
• W1988612012 hasConceptScore W1988612012C2779761222 @default.
• W1988612012 hasConceptScore W1988612012C502942594 @default.
• W1988612012 hasConceptScore W1988612012C526584372 @default.
• W1988612012 hasConceptScore W1988612012C55493867 @default.

• next